These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 1405361)

  • 1. Clinical strategies for arresting progression of renal disease.
    ter Wee PM; Donker AJ
    Kidney Int Suppl; 1992 Oct; 38():S114-20. PubMed ID: 1405361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure.
    Williams PS; Fass G; Bone JM
    Q J Med; 1988 Apr; 67(252):343-54. PubMed ID: 3205906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy.
    Sanaka T; Akizawa T; Koide K; Koshikawa S
    Ther Apher Dial; 2004 Jun; 8(3):232-40. PubMed ID: 15154877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods of cardio-renal protection in non-diabetic chronic nephropathies.
    Ruggenenti P; Remuzzi G
    Rocz Akad Med Bialymst; 2004; 49():116-23. PubMed ID: 15631326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current therapy of chronic renal failure].
    Vaslaki L
    Orv Hetil; 1998 Dec; 139(50):2995-9. PubMed ID: 9876458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to slow the progression of renal disease.
    Neuringer JR; Levey AS
    Semin Nephrol; 1994 May; 14(3):261-73. PubMed ID: 8036361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and prevention of blood pressure-related renal disease.
    Whelton PK; Perneger TV; Brancati FL; Klag MJ
    J Hypertens Suppl; 1992 Dec; 10(7):S77-84. PubMed ID: 1291660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?].
    Dussol B; Berland Y
    Nephrol Ther; 2006 May; 2(2):51-74. PubMed ID: 16895717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure.
    Meloni C; Tatangelo P; Cipriani S; Rossi V; Suraci C; Tozzo C; Rossini B; Cecilia A; Di Franco D; Straccialano E; Casciani CU
    J Ren Nutr; 2004 Oct; 14(4):208-13. PubMed ID: 15483780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying and slowing progressive chronic renal failure.
    Curtis B; Barrett BJ; Levin A
    Can Fam Physician; 2001 Dec; 47():2512-8. PubMed ID: 11785282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of progressive renal disease in diabetes mellitus.
    Aurell M; Björck S
    Kidney Int Suppl; 1992 May; 36():S38-42. PubMed ID: 1614066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential benefits of renal diets on cardiovascular risk factors in chronic kidney disease patients.
    Cupisti A; Aparicio M; Barsotti G
    Ren Fail; 2007; 29(5):529-34. PubMed ID: 17654313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid abnormalities in chronic renal failure, nephrotic syndrome and dialysis.
    Kes P
    Acta Med Croatica; 2001; 55(4-5):177-86. PubMed ID: 12398021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
    Ravera M; Paoletti E
    Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
    Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
    Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.